M.D. (Medicine), D.M. (Neurology)
Fellowship in Multiple Sclerosis (UWO Canada)
Fellowship in Movement Disorders (UWO Canada)

Personal Data
Name: Rajas Kalidas Deshpande
Date of Birth: January 7, 1970
Place of Birth: Aurangabad, M.S., India

Registration Numbers

70842	Maharashtra Medical Council ( Branch of MCI): M.B.B.S., M.D. ( Medicine) and D.M. (Neurology)
79270	College of Physicians and Surgeons of Ontario,Canada (CPSO)

Attachments: Ruby Hall Clinic, Sancheti Hospital, Lokmanya Hospital, Oyster and Pearl Hospital, Saishree Hospital

Education

2003 - 2006	Clinical Fellow, Multiple Sclerosis Clinic [Professor GPA Rice], Department of Clinical Neurological Sciences [Professor M Strong], London Health Sciences Centre – University Campus, University of Western Ontario, Canada http://www.lhsc.on.ca/programs/msclinic/handbook.pdf
	Simultaneously working in General Neurology Clinic with Professor Dr. GPA Rice attending routine and emergency tertiary referral Neurology cases.
2004 – 2006	Also simultaneously working in Neuro-Ophthalmology as an observer (Professor Dr. David Nicolle)
May – August 2003	Clinical Fellow, Movement Disorders (Professor M. Jog), Department of Clinical Neurological Sciences London Health Sciences Centre, University of Western Ontario Canada.
January 2002	D.M. Neurology (post doctoral specialty) Seth G.S. Medical College and King Edward VII Memorial Hospital, University of Mumbai, Parel, India
June 1997	M.D. General Medicine (post graduate specialty) Government Medical College, Dr. B.A. Marathwada University, Aurangabad, India
January 1992	M.B.B.S. (Medical school degree) Government Medical College, Dr. B.A. Marathwada University, Aurangabad, India

Professional Record

Since 2013	Director Neurology at Ruby Hall Clinic Pune.
Since April 2008	Consultant Neurophysician at various specialty hospitals in Pune.
2006 – 2008	Director, Department of Neurosciences and Senior Consultant Neurophysician, Aditya Birla Memorial Hospital, Thergaon, Pune, India.
2003 - 2006	Clinical Fellow, Multiple Sclerosis Clinic [Professor GPA Rice], Department of Clinical Neurological Sciences [Professor M Strong], London Health Sciences Centre – University Campus, University of Western Ontario, Canada (http://www.lhsc.on.ca/programs/msclinic/handbook.pdf ) Simultaneously working in General Neurology Clinic with Dr. GPA Rice attending routine and emergency tertiary referral Neurology cases. Also (simultaneously) observer in Neuro-ophthalmology (Professor Dr. David Nicolle), since January 2004. May-August 2003 - Clinical Fellow, Movement Disorders [Professor M Jog], Department of Clinical Neurological Sciences [Professor M Strong], London Health Sciences Centre – University Campus, University of Western Ontario, Canada
April 2001-Mar 2003	Lecturer and Clinician (Neurologist) Seth G.S. Medical College and King Edward VII Memorial Hospital, University of Mumbai, Parel, India.
2001	Neurology Senior Resident (SRIII) for 2 months, Seth G.S. Medical College and King Edward VII Memorial Hospital, University of Mumbai
2000-2001	Neurology Senior Resident (SRII) for 12 months, Seth G.S. Medical College and King Edward VII Memorial Hospital, University of Mumbai
1999-2000	Neurology Senior Resident (SRI) for 12 months, Seth G.S. Medical College and King Edward VII Memorial Hospital, University of Mumbai
1998	Lecturer, Internal Medicine and Consultant Physician Government Medical College, Nanded, M.S., India
1997	Lecturer, Internal Medicine and Consultant Physician, Mahatma Gandhi Mission Medical College, Aurangabad, M.S., India
1996-1997	General Medicine Chief resident (JRIII) for 10 months, Government Medical College, Dr. B.A. Marathwada University, Aurangabad, India
1995-1996	General Medicine Senior resident (JRII) for 12 months, Government Medical College, Dr. B.A. Marathwada University
1994-1995	General Medicine Junior resident (JRI) for 14 months, Government Medical College, Dr. B.A. Marathwada University
September 1993	Team Leader (Team B) sent for emergency response to Killari, Latur in India during the crisis due to devastating earthquake
1992-1993	Rotating Internship, Government Medical College Aurangabad, Marathwada University. January-March 1992 – Rural hospital, Paithan March-May 1992 – Primary Health Centre, Kannad May-July 1992 – Mobile Hospital for unreachable villages, Gangapur July 1992-Jan 1993 Civil Hospital, Hospital, Nanded District

Awards

2005-2006	Biogen Idec Canada Multiple Sclerosis Fellowship
2004-2005	Biogen Idec Canada Multiple Sclerosis Fellowship
2003-2004	Biogen Canada Multiple Sclerosis Fellowship
January 2002	First place standing at University of Mumbai for D.M. Neurology, Seth G.S. Medical College and King Edward VII Memorial Hospital, University of Mumbai
December 1992	Special certificate of appreciation by the State government of Maharashtra for handling the critical situations in the casualty (administrative and medical) during the month-long communal riots in India (Civil Hospital, Nanded)

Teaching Activities

Since 04/ 2006	Senior Consultant in Neurology, teaching Resident Doctors.
2003-2006	Clinical Fellow in Neurology, teaching neurology to the undergraduate and postgraduate students in the University of Western Ontario.
2001-2003	Lecturer in Neurology, Seth G.S. Medical College, Mumbai, India
2001	Neurology Senior Resident (SRIII) for 2 months, Seth G.S. Medical College and King Edward VII Memorial Hospital, University of Mumbai, Parel, India
2000-2001	Neurology Senior Resident (SRII) for 12 months, Seth G.S. Medical College and King Edward VII Memorial Hospital, University of Mumbai
1999-2001	Neurology Senior Resident (SRI) for 12 months, Seth G.S. Medical College and King Edward VII Memorial Hospital, University of Mumbai
1998-1999	Lecturer in Medicine, Govt. Medical College, Nanded, M.S., India
1996-1997	General Medicine Chief resident (JRIII) for 10 months, Govt. Medical College, Dr. B.A.M. University, Aurangabad, India
1995-1996	General Medicine Senior resident (JRII) for 12 months, Government Medical College,Dr. B.A. Marathwada University
	The above posts included teaching Postgraduate students of Neurology, Internal Medicine, Psychiatry, Nursing, Occupational therapy and Physiotherapy and Undergraduate students of Medical school, Nursing, Occupational Therapy and Physiotherapy. The post of a Lecturer is equivalent to that of an Assistant Professor in western university.
1993-1994	Assistant Lecturer in Pharmacology, Government Medical College, Nanded, India

Professional Organizations

1999-2001	President and Organizing Secretary, Maharashtra Association of Resident Doctors (MARD), the statewide organization for welfare of all residents (approximately 4,800) in the state of Maharashtra
Member, Maharashtra Medical Council (Affiliation: Medical Council of India)
Member, Indian Medical Association
Member, Neurological Society of India
Member of a three-member committee appointed by the state government of Maharashtra, India, for the welfare of Resident and Postgraduate Doctors and Students in the state (1999-2002)
Member, IHIQ Society and Hamilton Institute of Policy Research.

Roles In Clinical Trials And Research Projects
A Multicenter, Open-Label Immunogenicity and Safety Study of a Serum-Free Pre-Formulated Solution of AVONEX® (Interferon beta-1a) Administered Intramuscularly to Patients with Relapsing/Remitting Multiple Sclerosis
*Treating Neurologist

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Natalizumab in Subjects with Relapsing-Remitting Multiple Sclerosis
*Examining Neurologist  

A Multicenter, Prospective and Retrospective, Long-Term Observational Study with AVONEX® and Rebif® to Determine the Efficacy, Tolerability, and Safety in Subjects with Relapsing Multiple Sclerosis (MS)
*Examining Neurologist  

International, randomized, multicenter, phase III study in patients with relapsing-remitting multiple sclerosis comparing: double-blinded the safety, tolerability, and efficacy of Betaseron®/Betaferon® 250μg (8MIU) and Betaseron®/Betaferon® 500μg (16 MIU), both given subcutaneously every other day, and rater-blinded the safety, tolerability, and efficacy of Betaseron®/Betaferon® 250μg (8 MIU) s.c. e.o.d. with Copaxone® 20mg s.c once daily over a treatment period of 104 weeks.
*Treating Neurologist  

An Open-label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Natalizumab in Subjects with Multiple Sclerosis Who Have Completed Studies C-1801, C-1802, or C-1803
*Treating Neurologist

Extension Of Protocol HMR 1726D/2001, A Phase II Study Of The Safety And Efficacy Of TERIFLUNOMIDE (HMR1726) In Multiple Sclerosis With Relapses
*Treating Neurologist  

A randomized, double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of teriflunomide (HMR1726D) in reducing the frequency of relapses and delaying the accumulation of physical disability in subjects with multiple sclerosis with relapses  
*Evaluating Neurologist

A long-term follow-up of patients enrolled in the pivotal study of Betaseron (interferon beta 1b) in relapsing-remitting multiple sclerosis
*Treating Neurologist  

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-Ranging Study to investigate the Efficacy and Safety of Three Months administration of SB-683699 (150-1200mg twice daily) in Subjects with Relapsing Multiple Sclerosis
*Evaluating Neurologist  

A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study of Subcutaneous Daclizumab in Patients with Active, Relapsing Forms of Multiple Sclerosis
*Evaluating Neurologist  

Double blind, placebo controlled, randomized, parallel group, multicenter, phase III study in patients with a first clinical demyelinating event suggestive of multiple sclerosis to evaluate the safety, tolerability, and efficacy of 8 MIU (250 μg) interferon beta-1b (Betaseron®) given subcutaneously every other day over a period of up to 24 months
*Evaluating Neurologist  

Open-label, multi-center phase III extension of the double-blind, placebo-controlled BENEFIT study (no. 304747) to obtain long-term follow-up data of patients with clinically definite MS and patients with a first demyelinating event suggestive of MS treated with 8 MIU (250 μg) interferon beta-1b (Betaseron®) given subcutaneously every other day for at least 36 months.
*Evaluating Neurologist

Publications  
“The Natural History of Multiple Sclerosis” (Chapter 1) in Advances in Neurology: Multiple Sclerosis (Lippincott Williams and Wilkins) edited by Dr. Mark Freedman, with co authors Dr. M. Kremenchutzky and Dr. GPA Rice (published December 2005).  

Deshpande R, Kremenchutzky M, Rice GP. Clinical Spectrum:
Definition and Natural Progression of MS. IN Schapira AV, et al (eds)
Neurology: Basic and Clinical Neuroscience.  Mosby.  Philadelphia. Published Jan 2007.  

Case reports and poster presentation on “Cerebral cryptococcoma in an immunocompetent patient” Neurology, India, 2001
 

Case report “Landau- Kleffner Syndrome”, Neurology, India, 2001

CME chapter on “Management of Refractory Epilepsy” (co-author
DR. P.U. Shah), published at the UPICON 2000, a National Neurological Conference,
Lucknow, India, 2000

Conferences, Updates, Workshops And Scientific Meetings

October 2004	ECTRIMS (European Committee For research And Treatment In Multiple Sclerosis) International Meeting and Conference, Vienna, Austria.
February 2004	International Neuromuscular conference, London Ontario.
October 2003	Update on Epilepsy and Clinically Isolated Syndrome of Multiple Sclerosis, Toronto, Canada
January 2003	1st Indo Canadian conference and workshop on Parkinson’s Disease and Movement Disorders (MOVDIS 2003)
December 2001	Conference and Workshop on EEG, Telemetry and Epilepsy at the 2nd joint annual conference of Indian Epilepsy Association and Indian Epilepsy Society, Mumbai, India
January 2001 7th	National Movement Disorder And Parkinson’s Disease Surgery Workshop, Mumbai, India
January 2001	Neurology Update Conference, Bombay Hospital Institute of Medical Sciences, Mumbai, India
September 2000	Indo- UK workshop on Epilepsy, Chennai, India
1996	Nephrology National Conference, Aurangabad, M.S., India
1995	MAPICON – Medicine Conference , Maharashtra Chapter of the Association of Physicians of India at Nanded, Maharashtra.
1993	Organizing member, One Day update conference on Urosurgery advances, Nanded, India

Rajas Deshpande,
M.D. (Medicine), D.M. (Neurology)
Fellowship in Multiple Sclerosis (UWO Canada)
Fellowship in Movement Disorders (UWO Canada)
Consultant Neurologist
email: rajasdeshpande@gmail.com

I have worked in the primitive as well as modern healthcare systems which made me aware of a great variety of diseases, which in rural India predominantly included infectious and nutritional deficiency diseases, poisonings, snake bites, malaria, and unattended chronic diseases like diabetes, hypertension, chronic obstructive pulmonary disease, ischemic heart disease and, most commonly, tuberculosis of all types.

While training as a resident in general medicine in a government medical college hospital, I was first in line to manage all emergencies and referrals. As there was no specialty care, I was expected to handle all referrals including cardiology, neurology, gastroenterology, nephrology, psychiatry and infectious diseases, besides attending all other medical diseases. During this training I learned life saving procedures, pacing the heart, peritoneal and haemodialysis and plasmapheresis.

As a resident in neurology working at a tertiary care center, drawing from all over the country, I learned to handle neurological referrals of various kinds. The spectrum included stroke, extra pyramidal diseases, CNS infections, degenerative diseases, epilepsy, and nutritional, toxic, metabolic and demyelinating diseases. Managing these made me well versed with investigations such as DSA, CT SCAN, MRI, SPECT, as well as routine CSF studies. I was also trained in electromyography, nerve conduction studies and electroencephalography.

While acting as President & Organizing Secretary for the Maharashtra Association of Resident Doctors (MARD), I learnt organizational expertise (about 4,800 Resident Doctors are the members of this association) and contributed to obtaining better working and living conditions for resident doctors over a period of 18 months. This subsequently led to the restructuring of residency program with regards to remuneration and working conditions in the state of Maharashtra.

From June 2003 onwards till March 2006 I worked in the sophisticated Neurology set-up at the London Health Sciences Center, University of Western Ontario, London, Ontario, Canada.

While working as a Clinical Fellow in Neurology (Multiple Sclerosis and Demyelinating Diseases), I individually consulted and managed patients in Multiple Sclerosis (over 2500), Demyelinating diseases and General Neurology, including urgent Neurology. I also worked as either an examining or treating Neurologist for about 15 clinical trials in Multiple Sclerosis, most of these international and multicenter.

As a fellow in Movement Disorders I was exposed to patients with various Basal Ganglionic pathologies, and learnt to individually manage them. I also learnt injecting Botox to selected Neurology and Neuro-ophthalmology patients. Teaching Neurology to the undergraduate and postgraduate students of the University of Western Ontario was a part of my duties, and that gave me an insight into their excellent, modern and student-oriented teaching environment.

I also simultaneously worked as an observer in Neuro-Ophthalmology (Professor Dr. David Nicolle), and have had a great exposure to this rare branch of neurology over 2 years from 2004 till 2006.

I have authored a chapter on “The Natural history of Multiple Sclerosis“ as first author for ‘Advances in Neurology: Multiple Sclerosis and Demyelinating Diseases ’ Volume 97 (Published December 2005, Editor Dr. Mark Freedman, Ottawa; for Lippincott-Williams and Wilkins) ,and another on“Clinical Spectrum and Natural Progression of Multiple Sclerosis” (first author) for “Neurology: Basic and Clinical Neurosciences“(Editor Anthony Shapira, Mosby, Philadelphia, In Press)

During my trainings I was always fascinated by the importance of early recognition of treatable neurological diseases, and the alleviation of pain and discomfort that can be offered in many incurable neurological diseases if proper diagnosis is reached. I am interested in working in the field of Demyelinating diseases such as Multiple Sclerosis, and Movement Disorders, Neuro-ophthalmology, infections of the CNS, Epilepsy and Stroke, towards this objective.

I practice speciality Neurology in India, and aim to broaden the clinical, teaching and research options and achievements while preferably working in an academic/ scientific setting. I also aim to offer world–class Neurology care to the Indian patient, which, while being scientific and ethical, will not be out of reach for any deserving patient.

References
Dr.David Nicolle, Professor
Neuro-Ophthalmology
University Hospital 7th floor
University of Western Ontario
London Health Sciences Center
339 Windermere Road London Ontario, N6A5A5 Canada.
Tel: 519 663 3702
Email:dnicolle@uwo.ca

Dr. B.S. Singhal, Professor and Head
Department of Neurology
Bombay Hospital Institute of Medical Sciences Marine Lines Mumbai M.S. India. 400 020
Tel: 91 22 22064747, 22067676

Dr. P.U. Shah, Ex-Hon. Professor and Head,
Neurology Department
Seth G.S. Medical College and King Edward VII Memorial Hospital
Parel, Mumbai India
Telephone: 91 22 25170644
Cell: 91 98200 10328
Email: pushah@vsnl.com